Research Article

TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer

Table 1

Univariate/multivariate cox regression analysis for hub genes.

GeneUnivariate analysisMultivariate analysis
HR95% CI valueHR95% CI value

TPX21.0321.025–1.0381.96E − 201.0351.025–1.0456.07E − 13
TSPYL51.0431.024–1.0636.20E − 061.0341.007–1.0610.013
CENPF1.0601.038–1.0822.24E − 081.0440.975–1.1170.217
ASPM1.1931.119–1.2737.84E − 080.9210.744–1.1400.450
DLGAP51.0821.050–1.1163.54E − 071.0350.965–0.1100.340
CDC201.0091.004–1.0131.13E − 040.9980.990–1.0060.680
KIF20A1.0361.017–1.0561.87E − 040.9820.945–1.0210.357
NCAPG21.1201.054–1.1902.55E − 041.0200.898–1.1600.758
CCNB21.0261.009–1.0582.16E − 031.0000.964–1.0380.989
PBK1.0351.012–1.0582.33E − 030.9920.952–1.0350.726
PTTG11.0121.003–1.0205.23E − 031.0010.985–1.0210.922
MELK1.0331.009–1.0586.09E − 030.9470.873–1.0270.186
ARMCX11.0401.011–1.0706.69E − 030.9840.939–1.0320.509
ECT21.0161.003–1.0280.0120.9920.955–1.0320.701
CEP551.0331.006–1.0600.0151.0110.963–1.0620.647
BIRC51.0051.000–1.0100.0390.9970.987–1.0070.610
CDO11.0500.998–1.1060.0600.9950.930–1.0650.885
SFN1.0000.998–1.0000.1191.0030.999–1.0010.864
RRM21.0090.997–1.0210.1381.0030.985–1.0210.770
TOP2A1.0020.999–1.0050.1641.0000.992–1.0080.977
ENPP21.0100.990–1.0300.3211.0110.988–1.0350.350
MMP120.9960.984–1.0090.5950.9950.981–1.0090.485
CYP1B11.0030.984–1.0230.7371.0040.980–1.0280.755
TCEAL21.0030.983–1.0240.7430.9940.970–1.0200.662

HR: hazard ratio; CI: confidence interval.